RayBalance, a pioneering healthcare venture addresses sensorineural hearing loss with a novel photobiomodulation therapy. Our service-oriented model generates revenue through weekly fees for our comprehensive treatment. With WHO predicting 2.5 billion people suffering from hearing loss by 2050, we offer a compelling investment opportunity, merging innovative technology, clear regulatory pathway, minimal competition and vast market potential.